Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease.

Vivante A, Afek A, Frenkel-Nir Y, Tzur D, Farfel A, Golan E, Chaiter Y, Shohat T, Skorecki K, Calderon-Margalit R.

JAMA. 2011 Aug 17;306(7):729-36. doi: 10.1001/jama.2011.1141.

PMID:
21846854
2.

Body mass index in 1.2 million adolescents and risk for end-stage renal disease.

Vivante A, Golan E, Tzur D, Leiba A, Tirosh A, Skorecki K, Calderon-Margalit R.

Arch Intern Med. 2012 Nov 26;172(21):1644-50.

3.

Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.

Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG.

JAMA. 2006 Jul 26;296(4):421-6.

PMID:
16868300
4.

Risk of developing end-stage renal disease in a cohort of mass screening.

Iseki K, Iseki C, Ikemiya Y, Fukiyama K.

Kidney Int. 1996 Mar;49(3):800-5.

5.

Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.

Ma RC, Tam CH, Wang Y, Luk AO, Hu C, Yang X, Lam V, Chan AW, Ho JS, Chow CC, Tong PC, Jia W, Ng MC, So WY, Chan JC.

JAMA. 2010 Aug 25;304(8):881-9. doi: 10.1001/jama.2010.1191.

PMID:
20736472
6.

Risk of end-stage renal disease following live kidney donation.

Muzaale AD, Massie AB, Wang MC, Montgomery RA, McBride MA, Wainright JL, Segev DL.

JAMA. 2014 Feb 12;311(6):579-86. doi: 10.1001/jama.2013.285141.

7.

Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults.

O'Hare AM, Rodriguez RA, Hailpern SM, Larson EB, Kurella Tamura M.

JAMA. 2010 Jul 14;304(2):180-6. doi: 10.1001/jama.2010.924.

8.

A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.

Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP.

Am J Kidney Dis. 2007 Jun;49(6):763-75.

PMID:
17533019
9.

Kidney stones and kidney function loss: a cohort study.

Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Morgan C, Samuel S, Klarenbach SW, Curhan GC, Tonelli M; Alberta Kidney Disease Network.

BMJ. 2012 Aug 29;345:e5287. doi: 10.1136/bmj.e5287.

10.

Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.

Perkins RM, Kirchner HL, Hartle JE, Bucaloiu ID.

Clin Nephrol. 2013 Oct;80(4):256-62. doi: 10.5414/CN107905.

PMID:
23993165
11.

Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.

Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS.

Circulation. 2013 Feb 5;127(5):569-74. doi: 10.1161/CIRCULATIONAHA.112.123992. Epub 2012 Dec 28.

12.

Risk of end-stage renal disease associated with gout: a nationwide population study.

Yu KH, Kuo CF, Luo SF, See LC, Chou IJ, Chang HC, Chiou MJ.

Arthritis Res Ther. 2012 Apr 18;14(2):R83. doi: 10.1186/ar3806.

13.

Surgical treatment for patients with periodontal disease reduces risk of end-stage renal disease: a nationwide population-based retrospective cohort study.

Lee CF, Lin CL, Lin MC, Lin SY, Sung FC, Kao CH.

J Periodontol. 2014 Jan;85(1):50-6. doi: 10.1902/jop.2013.130015. Epub 2013 May 7.

PMID:
23646848
14.

Incidence and predictors of end stage renal disease among low-income blacks and whites.

Lipworth L, Mumma MT, Cavanaugh KL, Edwards TL, Ikizler TA, Tarone RE, McLaughlin JK, Blot WJ.

PLoS One. 2012;7(10):e48407. doi: 10.1371/journal.pone.0048407. Epub 2012 Oct 24.

15.

Familial Factors, Low Birth Weight, and Development of ESRD: A Nationwide Registry Study.

Ruggajo P, Skrunes R, Svarstad E, Skjærven R, Reisæther AV, Vikse BE.

Am J Kidney Dis. 2016 Apr;67(4):601-8. doi: 10.1053/j.ajkd.2015.11.015. Epub 2015 Dec 31.

PMID:
26747633
16.

Increased risk of tuberculosis in patients with end-stage renal disease: a population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease.

Hu HY, Wu CY, Huang N, Chou YJ, Chang YC, Chu D.

Epidemiol Infect. 2014 Jan;142(1):191-9. doi: 10.1017/S0950268813000551. Epub 2013 Mar 19.

PMID:
23510593
17.

Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease.

Hsu CY, Go AS, McCulloch CE, Darbinian J, Iribarren C.

Clin J Am Soc Nephrol. 2007 Jan;2(1):81-8. Epub 2006 Nov 29.

18.

Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.

Nee R, Martinez-Osorio J, Yuan CM, Little DJ, Watson MA, Agodoa L, Abbott KC.

Am J Kidney Dis. 2015 Oct;66(4):630-7. doi: 10.1053/j.ajkd.2015.04.011. Epub 2015 May 19.

PMID:
26002293
19.

Duration of end-stage renal disease and kidney transplant outcome.

Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, Wang Z, Baird B, Barenbaum L, Cheung AK.

Nephrol Dial Transplant. 2005 Jan;20(1):167-75. Epub 2004 Nov 16.

PMID:
15546892
20.

Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.

Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C.

Arch Intern Med. 2005 Apr 25;165(8):923-8.

PMID:
15851645

Supplemental Content

Support Center